See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2018_Oncomed_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001302573, Oncomed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 105,205,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,275,000 |
| 3 | remainder_Assets | 1,842,000 |
| 4 | LiabilitiesCurrent | 93,132,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 65,793,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,184,254 |
| 9 | ResearchAndDevelopmentExpense | 36,737,170 |
| 10 | remainder_Expenses | 862,984 |
| 11 | remainder_Revenues | 38,512,714 |
| 12 | remainder_NetIncome | 901,250 |
| 13 | remainder_ComprehensiveNetIncome | 124,089 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 110,322,000 |
| 1 | Liabilities | 158,925,000 |
| 2 | Expenses | 53,784,408 |
| 3 | Revenues | 38,512,714 |
| 4 | StockholdersEquity | -48,603,000 |
| 5 | NetIncome | -14,370,444 |
| 6 | ComprehensiveNetIncome | -14,308,400 |
| 7 | BaseVar | 181,284,730 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.893 |
| 9 | EconomicCapitalRatio | 1.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
